[1]
“FAVIPIRAVIR THERAPY FOR PATIENTS WITH COVID-19 PNEUMONIA: AN OBSERVATIONAL STUDY: Supawadee Suppadungsuk1 , Thananya Wongsinin1 , Sirawat Srichatrapimuk1 , Suppachok Kirdlarp1,2, Kulapong Jayanama1 , Kanin Thammavaranucupt1 , Dhanesh Pitidhammabhorn1 , Sithakom Phusanti1 , Nithita Nanthatanti1 and Somnuek Sungkanuparph1”, SEATROPH, vol. 52, no. 1, pp. 161–174, Oct. 2021, Accessed: Apr. 16, 2026. [Online]. Available: https://journal.seameotropmednetwork.org/index.php/jtropmed/article/view/429